PATENT CLAIM ANALYSIS

Application Number: 16000701
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability, solubility, or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 15):
The method of  claim 1 , wherein the solid dosage form has the property that the dissolution of meloxicam is at least about 30 times that of the reference dosage form when the designated time is 120 minutes.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15984055', '15988104', '15902770', '15986215', '15989734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8066901547144368
- 35 USC 102 Novelty (BERT): 0.536940743695083
- Combined Prediction Score: 0.7797152136125015
- Mean Citation Score: 342.537594
- Max Citation Score: 369.3147
- Similarity Product: 274.1138735776663

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test